Although the hypothesis of the anticancer properties of NSAIDs was proven in vitro and in vivo (as they are COX2 inhibitors), other research has showed that in cancer cells lacking COX2 or in the cells with knocked-down expression of COX2, NSAIDs had similar anticancer activity. Here, PTGS2 is linked to cancer.